Japan Medical Dynamic Marketing Full Year 2025 Earnings: EPS Misses Expectations

Japan Medical Dynamic Marketing (TSE:7600) Full Year 2025 Results

Key Financial Results

• Revenue: JP¥25.1b (up 8.4% from FY 2024).
• Net loss: JP¥461.0m (down by 136% from JP¥1.27b profit in FY 2024).
• JP¥17.51 loss per share (down from JP¥48.29 profit in FY 2024).

Our free stock report includes 1 warning sign investors should be aware of before investing in Japan Medical Dynamic Marketing. Read for free now.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Japan Medical Dynamic Marketing EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates.

Looking ahead, revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Healthcare industry in Japan.

Performance of the Japanese Healthcare industry.

The company's shares are down 1.4% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 1 warning sign for Japan Medical Dynamic Marketing that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.